The single dose kinetics of chloroquine and its major metabolite desethylchloroquine in healthy subjects.
about
Randomized dose-ranging controlled trial of AQ-13, a candidate antimalarial, and chloroquine in healthy volunteersChloroquine is grossly under dosed in young children with malaria: implications for drug resistanceSevere falciparum malaria. World Health Organization, Communicable Diseases ClusterPharmacokinetics of chloroquine and monodesethylchloroquine in pregnancy.Antimalarial pharmacokinetics and treatment regimens.Pharmacokinetics of intravenous amodiaquine.A dose-ranging study of the pharmacokinetics of hydroxy-chloroquine following intravenous administration to healthy volunteers.JPC-2997, a new aminomethylphenol with high in vitro and in vivo antimalarial activities against blood stages of Plasmodium.Design and Synthesis of Novel Hybrid Molecules against Malaria.Pharmacokinetics, pharmacodynamics, and allometric scaling of chloroquine in a murine malaria model.Pharmacokinetics of intramuscular amopyroquin in healthy subjects and determination of a therapeutic regimen for Plasmodium falciparum malaria.Disposition of amopyroquin in rats and rabbits and in vitro activity against Plasmodium falciparum.Chloroquine resistance in Plasmodium vivax.Artemisinin-naphthoquine combination therapy for uncomplicated pediatric malaria: a pharmacokinetic study.Chronic use of chloroquine disrupts the urine concentration mechanism by lowering cAMP levels in the inner medullaPharmacokinetics and efficacy of piperaquine and chloroquine in Melanesian children with uncomplicated malaria.Population pharmacokinetics of a three-day chloroquine treatment in patients with Plasmodium vivax infection on the Thai-Myanmar border.Efficacy of a loading dose of oral chloroquine in a 36-hour treatment schedule for uncomplicated plasmodium falciparum malaria.Protection against malaria after immunization by chloroquine prophylaxis and sporozoites is mediated by preerythrocytic immunity.Chloroquine is grossly overdosed and overused but well tolerated in Guinea-bissau.Pharmacokinetics, metabolism, and in vivo efficacy of the antimalarial natural product bromophycolide AClinical features and management of poisoning due to antimalarial drugs.High-Dose Chloroquine for Treatment of Chloroquine-Resistant Plasmodium falciparum Malaria.Pitfalls in estimating piperaquine elimination.Pharmacokinetics of the antimalarial drug, AQ-13, in rats and cynomolgus macaques.Cardiovascular toxicity and distribution kinetics of intravenous chloroquine.A case of urinary incontinence by hydroxychloroquine in a geriatric patient.Blood concentrations are better predictors of chioroquine poisoning severity than plasma concentrations: a prospective study with modeling of the concentration/effect relationships.Hematologic disposition of hydroxychloroquine enantiomers.Pharmacokinetics and pharmacodynamics of the leukotriene B4 receptor antagonist CP-105,696 in man following single oral administration.Characterizing Blood-Stage Antimalarial Drug MIC Values In Vivo Using Reinfection Patterns.
P2860
Q28469106-FBCD21FC-1A46-472F-86C8-BA75C121837CQ28539103-34C1F233-F2D1-4880-9D78-DFFC65D553EEQ29614923-017EB186-C58E-4561-811B-2F140EA8D266Q33676120-96A97ADE-7739-4519-8386-1ADB0F922C63Q34403100-D564F9B8-40AA-4F7E-9BD3-1961C08E4720Q34416195-FCF3A251-498F-44E1-8C5E-EB0968E1EBD5Q34417966-86C89252-6C03-4191-B5E0-191EF00E1BF6Q34922167-F5677BCE-5B02-44FC-82C4-B09B1EBC8E61Q35103178-344A5013-3CDC-4E54-8E29-F11691FF18FEQ35139464-7C590491-C744-4122-96FD-8ADB7EDA08BDQ35244822-160F7EFA-B56D-45CD-8D33-133A3838C7D2Q35300502-9D825784-7FE0-4D1D-ABFC-0D24D8636BE7Q35927662-23E01C03-D453-4E22-AC8C-06F352408FABQ35941440-DB023501-B203-401A-8110-90F8ABE14AE3Q36309457-05F6C8CC-2881-40E0-8356-452D018DFF97Q36422652-BDE0D1F5-372A-4975-89F1-CD6DDC6DA52CQ36634918-F412D99A-58E4-481F-9CE5-C01BE1611840Q36752995-B090F196-1B96-48DF-8B27-6392B08DB655Q36835495-691B34A4-C1D1-4D2A-B306-906687CEC86CQ37032859-9432A51F-BAC7-428C-AC88-BFD0F8EC01A5Q37244996-0C30D560-17AB-4CCC-8666-2A7AC5524FECQ39667043-43C19DD6-AAE9-48E3-B964-AE1CAFD8177FQ40223323-54ADC223-934D-49E1-B49F-E7E55759DFBFQ40668709-CD554864-6120-4A8A-89AE-767BDE19E3D6Q41913895-3B655BC4-B548-49C1-9EA7-967C998D92E6Q41915255-535B9D9D-FB36-4B57-BDB5-8E5682E698CEQ41927613-1F72B525-99EA-4EEF-929A-9BC6236B48A1Q41934443-590A14F5-FF1D-40D6-92FB-D6EB332CEEE1Q41934460-0681AD95-02C0-4135-ACC8-A6968EA98063Q42075145-1E814926-F99B-46A6-A150-08E9C8B3B053Q55513666-799B5D69-3A82-4CCD-AA32-4E8FC8B0F55D
P2860
The single dose kinetics of chloroquine and its major metabolite desethylchloroquine in healthy subjects.
description
1984 nî lūn-bûn
@nan
1984年の論文
@ja
1984年論文
@yue
1984年論文
@zh-hant
1984年論文
@zh-hk
1984年論文
@zh-mo
1984年論文
@zh-tw
1984年论文
@wuu
1984年论文
@zh
1984年论文
@zh-cn
name
The single dose kinetics of ch ...... loroquine in healthy subjects.
@en
type
label
The single dose kinetics of ch ...... loroquine in healthy subjects.
@en
prefLabel
The single dose kinetics of ch ...... loroquine in healthy subjects.
@en
P2093
P356
P1476
The single dose kinetics of ch ...... loroquine in healthy subjects.
@en
P2093
B Domeij-Nyberg
M Frisk-Holmberg
Y Bergqvist
P2888
P304
P356
10.1007/BF00542151
P577
1984-01-01T00:00:00Z